BibTeX
CSL-JSON
MLA
Harvard
Subcutaneous cavernous hemangioma visualized on an indium-111-octreotide scan
release_usu4czghlvfnpl5rpatykdhpji
by
P F Winter, J Lapke, R Winek
Published
in Journal of Nuclear Medicine.
1996 Volume 37, Issue 9, p1516-7
Abstract
Indium-111-octreotide, a somatostatin analog is the first commercially available receptor-based agent. It shares the binding site of naturally occurring somatostatin and is suitable for imaging somatostatin receptor-bearing tumors. An 111In-octreotide scan performed on a 6-wk old girl showed increased uptake in a subcutaneous cavernous hemangioma, which should be added to the list of lesions that can be visualized on an octreotide scan.
In text/plain
format
Archived Files and Locations
application/pdf 897.6 kB
file_qpbi65lr2bejdps54yzdmwgfs4
|
jnm.snmjournals.org (web) web.archive.org (webarchive) |
Read Archived PDF
Preserved and Accessible
PubMed
8790204
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links